The University of Arkansas for Medical Sciences has been awarded a $763,971 National Institutes of Health grant that will fund the purchase of biomedical research equipment with new capabilities unavailable elsewhere in the state.
UAMS scientist Samuel Mackintosh, Ph.D., received the NIH S10 High-End Instrumentation Award. It will be used to buy a mass spectrometer, which is used to identify and compare proteins essential for the development of new therapies for cancer and other diseases.
Mackintosh serves as co-director of the UAMS Proteomics Core, a shared resource at the UAMS Winthrop P. Rockefeller Cancer Institute.
The NIH grant also builds on recent efforts at UAMS to strengthen collaboration between research programs funded by the NIH Institutional Development Award (IDeA) program, which seeks to expand scientific research in 23 historically underfunded states and Puerto Rico.
The grant will support proteomics research through three Centers for Biomedical Research Excellence (COBRE), IDeA research centers at UAMS and Arkansas Children’s Hospital that focus on career development for young scientists and expansion of institutional research capabilities.
Other UAMS researchers who supported the instrument grant application include Kevin Raney, Ph.D.; Maria Almeida, Ph.D.; and Srinivas Ayyadevara, Ph.D.
In addition, Bioinformatics and Systems Biology Core will play a key role in analyzing data generated by the new mass spectrometer.
This federal grant will bolster the cancer institute’s ongoing efforts to receive National Cancer Institute Designation as well.